Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...

PFE’s weak performance can be linked to declining demand ... Analysts’ consensus opinion on PFE stock is reasonably bullish, with a “Moderate Buy” rating overall. Out of 22 analysts ...

In the latest trading session, Pfizer (PFE) closed at $22.15, marking a +0.48% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.13% for the day. On the other ...

CNBC highlights this by examining the historical performance of the broader market. Between 1960 and 2024, a $10,000 investment in the index would have grown to over $982,000 purely from stock ...

We recently published a list of the 11 Best Dividend Paying Stocks According to Hedge Funds. In this article, we are going to ...

US stocks saw choppy trading on Tuesday (April 15) as investors digested a new round of first-quarter earnings reports and ...

We think Pfizer stock is worth $42 per share ... the Internet of Things, and high-performance computing applications, which may last decades. Taiwan Semiconductor stock trades 42% below our ...

Tuesday was a relatively uneventful news day for Pfizer, especially following the pharmaceutical giant's disclosure on Monday ...

The stock's fall snapped a three-day winning streak.

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn’t one of them. The 10 stocks that made the cut ...